Severe Erosive Pill Esophagitis Induced by Crizotinib Therapy: A Case Report and Literature Review

Previous case reports have described esophagitis thought to be secondary to crizotinib, an oral tyrosine-kinase inhibitor used in the treatment of anaplastic lymphoma kinase- (ALK-) positive non-small cell lung cancer (NSCLC). In those reports, the interval development of esophagitis was between two...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Patrick, Fortinsky, Kyle J., Gallinger, Zane R., Tartaro, Piero
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5178341/
https://www.ncbi.nlm.nih.gov/pubmed/28053793
http://dx.doi.org/10.1155/2016/3562820

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5178341/
https://www.ncbi.nlm.nih.gov/pubmed/28053793
http://dx.doi.org/10.1155/2016/3562820

Ejemplares similares